Close
Nordic 9Nordic 9

Dentol Capital (investor - Others)

Spain
See something wrong or missing? Let us know
Offices:Madrid

Dentol Capital is the family office of David Devesa, a lawyer from Spain.

Average round investment:7.49M USD
Average number per year:1.0
Distribution: 2024 (1)2023 (1)
Portfolio companies: Spain Laminar Pharma
Mostly invests in: Spain Spain (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Dentol Capital

Name Criteria
France Advent France Biotechnology
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Fundación Alba Pérez
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Addendum Capital
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Ekarpen
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain CG Health Ventures
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Chamberí Ventures
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Fifty Years
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Spain GAEA Inversion
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Spain Ezten Venture Capital Fund
72%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Cleon Capital
72%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Top